CVS Health Corp (CVSH34)

B3


	Symbol		Exchange		Currency
	CVSH34		B3		BRL	Delayed
	CVS		NYSE		USD	Real-time
	CVS		CBOE Canada		CAD	Real-time
	CVS		Mexico		MXN	Delayed
	CVS		BIVA		MXN	Delayed
	1CVS		Milan		EUR	Real-time
	CVS		TradeGate		EUR	Delayed
	CVS		Frankfurt		EUR	Delayed
	CVSCL		Santiago		CLP	Delayed
	CVS		Santiago		USD	Delayed
	CVSm		Buenos Aires		ARS	Delayed
	CVS		Vienna		EUR	Real-time
	CVS		Lima		USD	Delayed

Currency in BRL

Disclaimer

35.02

+0.34(+0.98%)

Closed04/10

Fair Value

Day's Range

35.02

35.02

52 wk Range

27.36

39.65

CVSH34 Income Statement

Featured here, the Income Statement (earnings report) for CVS Health Corp, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

255,765

267,908

290,912

321,629

356,623

Total Revenues Growth

+31.89%

+4.75%

+8.59%

+10.56%

+10.88%

Cost Of Revenues

211,248

219,660

239,991

267,965

303,345

Gross Profit

44,517

48,248

50,921

53,664

53,278

Gross Profit Growth

+44.17%

+8.38%

+5.54%

+5.39%

-0.72%

Gross Profit Margin %

17.41%

18.01%

17.5%

16.69%

14.94%

Other Operating Expenses, Total

32,699

34,585

36,764

37,922

39,205

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+57%	+5.77%	+6.3%	+3.15%	+3.38%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	32,699	34,585	36,764	37,922	39,205
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

11,818

13,663

14,157

15,742

14,073

Operating Income Growth

+17.58%

+15.61%

+3.62%

+11.2%

-10.6%

EBIT Margin %

4.62%

5.1%

4.87%

4.89%

3.95%

Net Interest Expenses

-2,024

-2,109

-1,304

-1,449

-1,505

Net Interest Expenses Growth

-3.32%

-4.2%

+38.17%

-11.12%

-3.86%

Interest Expense, Total

-3,035

-2,907

-2,503

-2,287

-2,658

Interest And Investment Income

1,011

798

1,199

838

1,153

Other Non Operating Expenses, Total

-7

-12

-4

-4

-6

EBT, Excl. Unusual Items

9,787

11,542

12,849

14,289

12,562

Gain (Loss) On Sale Of Assets

-

-

-

-2,533

-349

Other Unusual Items, Total

-79

-1,440

-391

-5,803

-

EBT, Incl. Unusual Items

8,997

9,770

10,537

5,836

11,173

EBT, Incl. Unusual Items Growth

+539.9%

+8.59%

+7.85%

-44.61%

+91.45%

EBT, Incl. Unusual Items Margin

3.52

3.65

3.62

1.81

3.13

Income Tax Expense

2,366

2,569

2,548

1,509

2,805

Net Income to Company

6,631

7,192

7,989

4,327

8,368

Minority Interest

3

-13

12

-16

-24

Net Income

6,634

7,179

8,001

4,311

8,344

Net Income Growth

+1,216.84%

+8.22%

+11.45%

-46.12%

+93.55%

Net Income Margin %

2.59%

2.68%

2.75%

1.34%

2.34%

Preferred Dividend and Other Adjustments

5

-

-

-

-

Net Income to Common Excl. Extra Items

6,629

7,188

8,001

4,311

8,344

Basic EPS - Continuing Operations

5.1

5.49

6.07

3.29

6.49

Basic EPS - Continuing Operations Growth

+991.04%

+7.77%

+10.47%

-45.83%

+97.62%

Diluted EPS - Continuing Operations

5.08

5.47

6.02

3.26

6.47

Diluted EPS - Continuing Operations Growth

+988.36%

+7.68%

+10.05%

-45.85%

+98.47%

Basic Weighted Average Shares Outstanding

1,301

1,309

1,319

1,312

1,285

Diluted Weighted Average Shares Outstanding

1,305

1,314

1,329

1,323

1,290

Dividend Per Share

2

2

2

2.2

2.42

Dividend Per Share Growth

0%

0%

0%

+10%

+10%

EBITDA

16,189

18,104

18,643

19,966

18,439

EBITDA Growth

+26.78%

+11.83%

+2.98%

+7.1%

-7.65%

EBITDA Margin %